Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1/2 2Phase 3 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 47Squamous Cell Carcinoma of Head and Neck 30Head and Neck Neoplasms 17Colonic Neoplasms 15Rectal Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 7Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Squamous Cell 4Recurrence 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma 3Oropharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Laryngeal Diseases 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Tongue Neoplasms 1Stomach Neoplasms 1Rectal Diseases 1Radiation Injuries 1Precancerous Conditions 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Intestinal Neoplasms 1

Interventions

Fluorouracil 16Cisplatin 11Radiotherapy 8Oxaliplatin 8Leucovorin 8Neoadjuvant Therapy 5Capecitabine 5Paclitaxel 4Nivolumab 4Docetaxel 4Trastuzumab 3Carboplatin 3dehydroftorafur 2Radiation 2Irinotecan 2Epirubicin 2Drug Therapy 2Chemotherapy, Adjuvant 2zolbetuximab 1zimberelimab 1zanidatamab 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1tislelizumab 1pertuzumab 1pembrolizumab 1gastrin immunogen 1Taxes 1Surgical Procedures, Operative 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Adenocarcinoma Of Esophagus × Cetuximab × Clear all
NCT01107639 2020-10-20

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Swiss Cancer Institute

Phase 3 Completed
297 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡